Brand Institute is the global leader in pharmaceutical and healthcare-related brand name and identity development. Our subsidiary, Drug Safety Institute (DSI), is comprised of full-time experts who formerly served as key naming, packaging and labeling regulatory officials at FDA, EMA, Health Canada, AMA and WHO. In their former roles, many of our regulatory experts authored the name safety guidance currently in use at their respective agencies. Add in the industry’s most prolific creative teams, a group of seasoned trademark attorneys and paralegals, a proven and proprietary research model, and 13 consecutive years with a majority Share of Market Regulatory Name Approvals, and you have a recipe for success!
OUR 2019 Rx / USAN / INN SHARE OF MARKET APPROVALS
Our approach to developing consumer and B2B brand names addresses the marketing, legal, and linguistic challenges inherent to the brand name development process. We combine exceptional creative with efficient and comprehensive trademark screens, then test those names with your target audience while checking for negative or unintended connotations and associations. All the while we involve your team to ensure process and strategy alignment, and ultimately the enthusiastic adoption of your product’s brand name and visual identity internally and externally.
Your corporate brand name and visual identity are critically important to your company’s success and overall branding efforts. A great corporate identity helps you stand out against your competition, encourages the development of your company’s culture, and provides your customers clarity regarding your purpose, mission, and direction. With a portfolio of over 175 corporate identities developed (and counting!), we have the experience and expertise to develop a memorable, ownable and meaningful corporate identity for your organization.
”I appreciate all of our clients for having placed their trust in Brand Institute over the last quarter-century.
Chairman & CEO